External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Haematology ICAPA 2025
Roche and Genentech at

ICAPA 2025

September 10 - September 13
Kyoto, Japan / Virtual (Hybrid)
icongroup.co.jp
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
01:30 PM
Duration 60mins Kyoto, Japan
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Crovalimab▼ as Add-On Therapy in Patients With Antiphospholipid Syndrome and Recurrent Thrombosis
Doruk Erkan, Ricard Cervera, Mark Crowther, Jason Knight, Thomas Ortel, Savino Sciascia, Allison Hsia, Sasha Sreckovic, Hannah Cohen
Haematology | Paroxysmal Nocturnal Hemoglobinuria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.